How many Aligos Therapeutics shares are in issue?
Aligos Therapeutics has 3,587,892 shares in issue.
What is the market cap of Aligos Therapeutics?
The market capitalisation of Aligos Therapeutics is USD 92.28 M.
What is the 1 year trading range for Aligos Therapeutics share price?
Aligos Therapeutics has traded in the range of US$ 6.76 to US$ 30.00 during the past year.
What is the PE ratio of Aligos Therapeutics?
The price to earnings ratio of Aligos Therapeutics is -1.04.
What is the cash to sales ratio of Aligos Therapeutics?
The cash to sales ratio of Aligos Therapeutics is 5.88.
What is the reporting currency for Aligos Therapeutics?
Aligos Therapeutics reports financial results in USD.
What is the latest annual turnover for Aligos Therapeutics?
The latest annual turnover of Aligos Therapeutics is USD 15.53M.
What is the latest annual profit for Aligos Therapeutics?
The latest annual profit of Aligos Therapeutics is USD -87.68M.
What is the registered address of Aligos Therapeutics?
The registered address for Aligos Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801.
What is the Aligos Therapeutics website address?
The website address for Aligos Therapeutics is www.aligos.com.
Which industry sector does Aligos Therapeutics operate in?
Aligos Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
